2024
Role of CD93 in podocytopathies.
- Dr. Gabriel Cara-Fuentes
- Stefano Da Sacco, PhD
REduced-dose Steroid PrOtocol for childhood Nephrotic SyndromE (RESPONSE): a pilot open-label randomized, controlled trial.
- Dr. Rulan Parekh
- Dr. Larry Greenbaum, PhD
- Dr. Cal Robinson
JAK/STAT Pathway Gene Expression and Urinary Biomarkers in Focal Segmental Glomerulosclerosis and Minimal Change Disease.
- Dr. Carol Shen
- Dr. Jennifer Yee, PhD
Treatment Practice Pattern and Clinical Trajectory in Pediatric Patients with C3 Glomerulopathy.
- Dr. Ana Solis Zavala
- Dr. Bradley Dixon
2023
Genetic sequencing and the anti-nephrin antibody in pediatric nephrotic syndrome.
- Dr. Matthew Sampson
- Dr. William Smoyer
Targeting Novel Pathways to Reduce Proteinuria and Scarring in Nephrotic Syndrome.
- Julie Dougherty, PhD
- Dr. Gabriel Cara Fuentes
Single particle reconstruction of PAR 3/4 heterodimer using cryoEM.
- Kaushik Muralidharan, PhD
- Dr. Marvin Nieman
Proteomic analyses of molecular mechanisms of podocyte injury in idiopathic nephrotic syndrome.
- Dr. Yu Kamigaki
- Timothy Cummins, PhD
The role of sex hormones on chronic kidney disease progression.
- Dr. Hannah Kim
- Dr. Rebecca Ruebner
2022
Urine single-cell RNA-sequencing in Minimal Change Disease.
- Dr. Yaacov Frishberg
- Maya Schuldiner, PhD
Defining the role of chloride channel 5 in maintaining podocyte structure and functions.
- Dr. Rasheed Gbadegesin
- Dr. Laura Mariani
Scaffold protein Sh3bp2 plays a central role in pathogenesis of nephrotic syndrome.
- Dr. Tarak Srivastava
- Mukut Sharma, PhD
Sex-hormones and its significance for podocytes: a promising novel therapeutic concept in a sex dependent manner.
- Dr. Jun Oh
- Lars Fester, PhD